Monoclonal Antibody Therapy in Treating Patients With Recurrent or Refractory Lymphoma

Summary

RATIONALE: Monoclonal antibodies can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells. PURPOSE: Phase I trial to study the effectiveness of monoclonal antibody therapy in treating patients who have recurrent or refractory lymphoma.

Timeline

Start

2000-11

Primary completion

—

Completion

—

Drugs

Indications